Gene · 5515
Papers3,188
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,188
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PGC7 Regulates Genome-Wide DNA Methylation by Regulating ERK-Mediated Subcellular Localization of DNMT1. | Int J Mol Sci | 2023 | 36834503 | PubTator, text mining | PubMed |
| Morphological and Molecular Bases of Male Infertility: A Closer Look at Sperm Flagellum. | Genes (Basel) | 2023 | 36833310 | PubTator, text mining | PubMed |
| Caveolin-1-Related Intervention for Fibrotic Lung Diseases. | Cells | 2023 | 36831221 | PubTator, text mining | PubMed |
| Aurora Kinase A Regulation by Cysteine Oxidative Modification. | Antioxidants (Basel) | 2023 | 36830089 | PubTator, text mining | PubMed |
| Profiling the miRNA from Exosomes of Non-Pigmented Ciliary Epithelium-Derived Identifies Key Gene Targets Relevant to Primary Open-Angle Glaucoma. | Antioxidants (Basel) | 2023 | 36829964 | PubTator, text mining | PubMed |
| Luteolin directly binds to KDM4C and attenuates ovarian cancer stemness via epigenetic suppression of PPP2CA/YAP axis. | Biomed Pharmacother | 2023 | 36804120 | PubTator, text mining | PubMed |
| Small-Molecule-Mediated Stabilization of PP2A Modulates the Homologous Recombination Pathway and Potentiates DNA Damage-Induced Cell Death. | Mol Cancer Ther | 2023 | 36788429 | PubTator, text mining | PubMed |
| VPA mediates bidirectional regulation of cell cycle progression through the PPP2R2A-Chk1 signaling axis in response to HU. | Cell Death Dis | 2023 | 36781846 | PubTator, text mining | PubMed |
| Study on the evolutionary game of the three parties in the combined medical and health-care PPP project. | Front Public Health | 2023 | 36778571 | PubTator, text mining | PubMed |
| PP2Ac/STRN4 negatively regulates STING-type I IFN signaling in tumor-associated macrophages. | J Clin Invest | 2023 | 36757811 | PubTator, text mining | PubMed |
| Hsa-miR-409-3p regulates endothelial progenitor senescence via PP2A-P38 and is a potential ageing marker in humans. | J Cell Mol Med | 2023 | 36756741 | PubTator, text mining | PubMed |
| A Virus-Packageable CRISPR System Identifies Host Dependency Factors Co-Opted by Multiple HIV-1 Strains. | mBio | 2023 | 36744886 | PubTator, text mining | PubMed |
| Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | Mol Cell | 2023 | 36736316 | PubTator, text mining | PubMed |
| Establishment of a PPP2CA homozygous knockout human embryonic stem cell line via CRISPR/Cas9 system. | Stem Cell Res | 2023 | 36724553 | PubTator, text mining | PubMed |
| Irradiated lung cancer cell-derived exosomes modulate macrophage polarization by inhibiting MID1 via miR-4655-5p. | Mol Immunol | 2023 | 36709645 | PubTator, text mining | PubMed |
| Key circRNAs from goat: discovery, integrated regulatory network and their putative roles in the differentiation of intramuscular adipocytes. | BMC Genomics | 2023 | 36707755 | PubTator, text mining | PubMed |
| Synergy of ruthenium metallo-intercalator, [Ru(dppz)2(PIP)]2+, with PARP inhibitor Olaparib in non-small cell lung cancer cells. | Sci Rep | 2023 | 36702871 | PubTator, text mining | PubMed |
| Targeting protein phosphatases in cancer immunotherapy and autoimmune disorders. | Nat Rev Drug Discov | 2023 | 36693907 | PubTator, text mining | PubMed |
| Transportin 1 is a major nuclear import receptor of the nitric oxide synthase interacting protein. | J Biol Chem | 2023 | 36690276 | PubTator, text mining | PubMed |
| Aggression Results in the Phosphorylation of ERK1/2 in the Nucleus Accumbens and the Dephosphorylation of mTOR in the Medial Prefrontal Cortex in Female Syrian Hamsters. | Int J Mol Sci | 2023 | 36674893 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5515/papers?page=12